Public-Private Partnerships Formed To Develop Zika Vaccine Candidates

Reuters: France’s Sanofi partners U.S. Army to speed up Zika vaccine
“French drugmaker Sanofi said on Wednesday it had struck a research and development deal with the U.S. Army to speed up the development of a vaccine against the mosquito-borne Zika virus…” (Blamont/Hirschler, 7/6).

Wall Street Journal: Brazilian Researchers Join With U.S. in Hunt for Zika Vaccine
“A leading Brazilian biomedical research center is teaming up with the U.S. and the World Health Organization in the latest effort to develop a vaccine for the mosquito-borne Zika virus. The Butantan Institute here has said it would partner with a division of the U.S. Department of Health and Human Services to develop the new vaccine for the virus…” (Johnson/Jelmayer, 7/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.